title: RIP2 polymorphisms in inflammatory bowel diseases.
authors.forename: R
authors.initials: R
authors.lastname: Thiébaut
authors.forename: V
authors.initials: V
authors.lastname: Douchin
authors.forename: C
authors.initials: C
authors.lastname: Jung
authors.forename: F
authors.initials: F
authors.lastname: Merlin
authors.forename: J F
authors.initials: JF
authors.lastname: Colombel
authors.forename: M
authors.initials: M
authors.lastname: Lemann
authors.forename: S
authors.initials: S
authors.lastname: Almer
authors.forename: C
authors.initials: C
authors.lastname: Tysk
authors.forename: C
authors.initials: C
authors.lastname: O'Morain
authors.forename: M
authors.initials: M
authors.lastname: Gassull
authors.forename: Y
authors.initials: Y
authors.lastname: Finkel
authors.forename: H
authors.initials: H
authors.lastname: Zouali
authors.forename: L
authors.initials: L
authors.lastname: Pascoe
authors.forename: J P
authors.initials: JP
authors.lastname: Hugot
mesh_terms: D016022:Case-Control Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D053475:Receptor-Interacting Protein Serine-Threonine Kinase 2 / Q000235:genetics*
chemical_list: C506253:RIPK2 protein, human; D053475:Receptor-Interacting Protein Serine-Threonine Kinase 2